Lederspan

What Is Lederspan and What Is It Used For?

Lederspan contains triamcinolone hexacetonide, a synthetic glucocorticoid (corticosteroid) that suppresses immune system activity and reduces inflammation. It is injected directly into or around joints to treat inflammatory joint conditions including rheumatoid arthritis, other forms of arthritis, and soft tissue inflammation such as bursitis, tendinitis, and epicondylitis.

Triamcinolone hexacetonide belongs to the glucocorticoid class of medications, which are synthetic analogues of cortisol, a hormone naturally produced by the adrenal glands. When injected locally into a joint (intra-articular injection) or around a joint (periarticular injection), it provides powerful anti-inflammatory effects directly at the site of inflammation. This targeted approach means that the drug acts primarily where it is needed, with significantly lower systemic absorption compared to oral corticosteroids.

The primary advantage of triamcinolone hexacetonide over other injectable corticosteroids is its remarkably low aqueous solubility. This pharmacological property means the drug dissolves very slowly from the injection site, creating a sustained depot of active medication within the joint. Clinical studies published in the Annals of the Rheumatic Diseases and other peer-reviewed journals have consistently demonstrated that triamcinolone hexacetonide provides longer-lasting symptom relief compared to other commonly used intra-articular corticosteroids such as triamcinolone acetonide or methylprednisolone acetate.

Lederspan is indicated for the treatment of several inflammatory musculoskeletal conditions:

• Rheumatoid arthritis (RA): To reduce synovial inflammation, pain, and swelling in affected joints. Intra-articular corticosteroid injection is recommended by the European Alliance of Associations for Rheumatology (EULAR) as an adjunct to systemic therapy for acute joint flares.
• Osteoarthritis with synovitis: When an osteoarthritic joint develops secondary inflammation causing significant pain and swelling, intra-articular corticosteroid injection can provide weeks to months of relief.
• Other forms of arthritis: Including psoriatic arthritis, juvenile idiopathic arthritis (in older children under specialist care), crystal arthropathies, and reactive arthritis.
• Bursitis: Inflammation of the bursae (fluid-filled sacs cushioning bones, tendons, and muscles near joints), commonly affecting the shoulder, hip, or knee.
• Tendinitis and tenosynovitis: Inflammation of tendons and their surrounding sheaths, though the injection must never be made directly into the tendon substance.
• Epicondylitis: Commonly known as tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis), where periarticular injection around the affected area can reduce inflammation and pain.

The mechanism of action involves suppression of the inflammatory cascade at multiple levels. Triamcinolone hexacetonide inhibits phospholipase A2, thereby blocking the production of pro-inflammatory prostaglandins and leukotrienes. It also reduces capillary permeability, decreases the migration of inflammatory cells into the joint, and suppresses the release of inflammatory cytokines. In combination, these effects lead to a marked reduction in joint swelling, warmth, tenderness, and pain.

What Should You Know Before Receiving Lederspan?

Lederspan must not be used if you are allergic to triamcinolone or any of the other ingredients. It is contraindicated in the presence of active joint infection, systemic fungal infections, or gonorrhoea. Your doctor will carefully assess your medical history and current health status before administering the injection.

Contraindications

You must not receive Lederspan if you have:

• Known hypersensitivity to triamcinolone hexacetonide or any of the excipients, including benzyl alcohol, polysorbate 80, or sorbitol
• Active infection at or near the injection site: Injecting a corticosteroid into an infected joint can worsen the infection and has potentially serious consequences. Any suspected septic arthritis must be excluded before injection.
• Certain systemic infections: Including active tuberculosis and disseminated gonococcal infection, as corticosteroids suppress the immune response needed to fight these infections
• Joint instability: If the target joint is significantly unstable, intra-articular injection may not be appropriate as the steroid cannot address the underlying structural problem and may mask symptoms that would otherwise guide treatment

Warnings and Precautions

Inform your doctor or healthcare provider before receiving Lederspan if any of the following apply to you:

• Active infection elsewhere in the body: Lederspan should not be given without concurrent appropriate antimicrobial treatment, as the immunosuppressive effect may worsen existing infections or reactivate latent infections such as tuberculosis.
• Recent vaccination: High-dose corticosteroids can impair the immune response to certain vaccines, particularly live vaccines. Discuss the timing of any recent or planned vaccinations with your doctor.
• Severe heart failure or kidney impairment: Corticosteroids can cause fluid retention and electrolyte disturbances, which may exacerbate these conditions.
• High blood pressure (hypertension): Corticosteroids may elevate blood pressure through fluid and sodium retention.
• Osteoporosis or risk factors for osteoporosis: Systemic absorption of corticosteroids, even from local injections, can contribute to bone mineral density loss over time with repeated doses.
• Diabetes mellitus: Corticosteroids can elevate blood glucose levels, which may require temporary adjustment of antidiabetic medication. Blood glucose monitoring is particularly important in the days following injection.
• Depression or history of psychiatric disorders: Corticosteroids can occasionally trigger mood changes, euphoria, insomnia, or psychotic symptoms.

Menstrual irregularities and postmenopausal vaginal bleeding have been reported in women treated with Lederspan. These effects are usually transient and resolve without specific treatment, but should be discussed with your healthcare provider.

Children and Adolescents

Lederspan must not be given to premature infants or neonates (up to 4 weeks of age) because it contains benzyl alcohol, which can cause toxic and anaphylactoid reactions in very young children. In children under 3 years of age, Lederspan should only be used with extreme caution and under close specialist supervision. Repeated corticosteroid exposure in children can suppress growth, and height and weight should be monitored regularly during treatment. In older children with juvenile idiopathic arthritis, intra-articular triamcinolone hexacetonide is an established treatment option recommended by paediatric rheumatology guidelines, but should be administered by experienced specialists.

Pregnancy and Breastfeeding

If you are pregnant, planning a pregnancy, or breastfeeding, inform your doctor before receiving Lederspan. The medication should only be used during pregnancy when the expected benefit to the mother clearly outweighs the potential risk to the foetus. Animal studies have shown that corticosteroids can affect foetal development, including a small increased risk of cleft palate when used during the first trimester. However, intra-articular injection delivers a much smaller systemic dose than oral corticosteroid therapy.

Triamcinolone hexacetonide does pass into breast milk, but at the doses used for intra-articular injection, the amount reaching the nursing infant is considered clinically insignificant. Nevertheless, discuss the risks and benefits with your doctor if you are breastfeeding.

Fertility: Corticosteroid treatment has been associated with menstrual irregularities and amenorrhoea (absence of menstrual periods) in women. These effects are typically reversible upon discontinuation of treatment.

Driving and Using Machines

Lederspan is not expected to affect your ability to drive or operate machinery. However, you should assess your own condition after receiving the injection, as the treated joint may initially be tender and the instruction to rest the joint for up to 12 hours may limit certain activities.

Important Information About Excipients

Lederspan contains several excipients that may require special consideration:

• Benzyl alcohol (9 mg per ml): May cause allergic reactions in sensitive individuals. It is associated with the risk of serious breathing difficulties in young children and must not be given to premature babies or neonates. It should not be used for more than one week in children under 3 years of age unless specifically recommended by a doctor. Patients with impaired liver or kidney function should consult their doctor before receiving this medication, as large amounts of benzyl alcohol can accumulate and cause metabolic acidosis.
• Sorbitol (450 mg per ml): Sorbitol is a source of fructose. If you or your child has been diagnosed with hereditary fructose intolerance, a rare genetic condition that prevents the body from breaking down fructose, inform your doctor before receiving this medicine.
• Polysorbate 80 (4 mg per ml): May cause allergic reactions. Inform your doctor if you have any known allergies to polysorbate.

How Does Lederspan Interact with Other Drugs?

Lederspan can interact with several classes of medications, including antidiabetic agents, antihypertensives, cardiac glycosides, and certain antiepileptic drugs. Some medications can reduce the effectiveness of Lederspan, while others may increase its effects or the risk of side effects. Always tell your doctor about all medications you are taking.

Although Lederspan is administered locally rather than systemically, a proportion of the active ingredient is absorbed into the bloodstream over time. This systemic absorption means that drug interactions, while generally less pronounced than with oral corticosteroids, can still occur. The likelihood and clinical significance of interactions increase with higher doses and more frequent injections.

Inform your doctor or pharmacist about all medications you are currently using, have recently used, or might use, including over-the-counter medicines, herbal supplements, and vitamins.

The interactions listed above are not exhaustive. Always provide your doctor with a complete medication list before receiving a Lederspan injection. This includes prescription medicines, over-the-counter products, and herbal or nutritional supplements.

What Is the Correct Dosage of Lederspan?

The dose of Lederspan ranges from 2 to 20 mg per injection, depending on the size of the joint being treated and the severity of inflammation. Large joints such as the knee or shoulder typically require 10–20 mg, while medium-sized joints such as the elbow or wrist need 5–10 mg. Your doctor will determine the appropriate dose for your specific condition.

Lederspan is always administered by a healthcare professional. You will not need to prepare or measure the dose yourself. The injection is given using strict aseptic technique, similar to the sterile procedure used for a lumbar puncture. The suspension must be shaken well before use to ensure uniform distribution of the active ingredient.

Intra-articular Injection (Into the Joint)

The dose is individualised based on the size of the joint and the amount of synovial fluid present. It is critical that the injection is placed accurately within the synovial cavity. The healthcare professional will choose an injection site where the synovial membrane is most superficial and free from major blood vessels and nerves.

When there is a large amount of synovial fluid in the joint (an effusion), the doctor may aspirate (withdraw) some of the fluid before administering the injection. This can improve the accuracy of drug delivery and provide additional diagnostic information.

Periarticular Injection (Around the Joint)

For conditions affecting structures surrounding the joint, the following dosing guidelines apply:

• Bursitis: 10–20 mg (0.5–1 ml), depending on the size of the bursa and the intensity of the inflammatory process. In most cases, a single injection is sufficient and repeat injection is not required.
• Tendinitis, tenosynovitis, epicondylitis: 10–20 mg (0.5–1 ml). The injection is placed around the tendon sheath or at the site of maximal tenderness – never directly into the tendon itself, as this risks tendon weakening or rupture. The need for repeat injections is assessed based on the therapeutic response.

Children and Adolescents

Lederspan must not be given to premature infants or babies up to 3 years of age due to the benzyl alcohol content. In older children, doses are determined on an individual basis by the treating specialist, typically a paediatric rheumatologist. The dose is adjusted according to the child's age, weight, and the size of the joint being treated. Growth monitoring is essential during treatment.

After the Injection

Patients are advised to rest the treated joint and remain relatively still for up to 12 hours after the injection. This period of rest helps the drug settle within the synovial cavity and reduces the likelihood of post-injection discomfort. Normal activities can usually be resumed the following day, but strenuous exercise or heavy loading of the treated joint should be avoided for several days.

Mixing with Local Anaesthetics

Lederspan may be mixed with lidocaine (lignocaine) injection solution without preservatives to provide immediate pain relief at the injection site. It is important that preservative-containing solutions (those containing methylparaben, propylparaben, phenol, etc.) are not used, as these can cause flocculation (clumping) of the corticosteroid suspension. The Lederspan should be drawn into the syringe first, followed by the anaesthetic, and the mixture should be used immediately after gentle shaking.

What Are the Side Effects of Lederspan?

Like all medicines, Lederspan can cause side effects, although not everyone experiences them. The most common side effect is temporary swelling, pain, and warmth in the treated joint. Serious side effects such as severe allergic reactions are rare. Contact your doctor immediately if you experience facial swelling, difficulty breathing, or widespread hives after injection.

The side effects of intra-articular corticosteroid injections are generally local and transient. However, because a proportion of the drug is absorbed systemically, side effects associated with systemic corticosteroid therapy can occasionally occur, particularly with higher doses or frequent injections. The frequency categories used below follow the standard medical convention established by the Council for International Organizations of Medical Sciences (CIOMS).

It is important to distinguish between a post-injection flare (a common, self-limiting reaction that resolves within 1–2 days) and septic arthritis (a bacterial infection in the joint). If pain and swelling worsen progressively after the first 48 hours, or if you develop fever, seek urgent medical attention as this may indicate joint infection requiring immediate treatment with antibiotics.

If you experience any side effects not listed above, or if any side effect becomes severe or persistent, contact your doctor, nurse, or pharmacist. Reporting suspected adverse effects helps to continuously monitor the benefit-risk profile of the medication.

How Should Lederspan Be Stored?

Lederspan should be stored below 25°C and must not be frozen. Keep the medicine out of the sight and reach of children. Do not use after the expiry date printed on the label. Unused or expired medicine should be disposed of according to local pharmaceutical waste guidelines.

Proper storage of Lederspan is essential to maintain the quality and efficacy of the suspension. As an injectable pharmaceutical product, it is typically stored and handled in healthcare settings (hospitals, clinics, and pharmacies) rather than in the home.

Key storage requirements include:

• Temperature: Store at or below 25°C (77°F). Do not refrigerate excessively, and never freeze the product, as freezing can irreversibly alter the suspension and render it unsuitable for injection.
• Light protection: Store in the original packaging to protect from light.
• Expiry date: The expiry date (EXP) printed on the label refers to the last day of that month. Do not use the medicine after this date.
• Inspection before use: Before administration, the healthcare professional should inspect the vial visually. The suspension should be shaken well and should appear uniformly white to off-white. Do not use if there is visible discolouration, particulate matter, or if the vial seal is compromised.
• Disposal: Do not dispose of medicines via household waste or the sewage system. Return unused medicines to a pharmacy for proper disposal to protect the environment.

What Does Lederspan Contain?

The active substance in Lederspan is triamcinolone hexacetonide at a concentration of 20 mg per ml. The inactive ingredients include polysorbate 80, sorbitol, benzyl alcohol, and water for injections.

Each millilitre of Lederspan suspension for injection contains:

• Active ingredient: Triamcinolone hexacetonide 20 mg
• Excipients:
  • Polysorbate 80 – 4 mg (emulsifier and stabiliser)
  • Sorbitol – 450 mg (tonicity agent; source of fructose)
  • Benzyl alcohol – 9 mg (preservative)
  • Water for injections – q.s. (to volume)

Appearance: Lederspan is supplied as a white to off-white sterile suspension in clear glass injection vials with a grey rubber stopper and aluminium flip-off seal.

Available pack sizes: 1 × 1 ml, 12 × 1 ml, and 50 × 1 ml vials. Not all pack sizes may be marketed in all countries.

The pH of the injection suspension is 4.0–8.0. Lederspan should not be mixed with solutions containing preservatives such as methylparaben, propylparaben, or phenol, as these can cause flocculation (clumping) of the steroid particles. It may, however, be mixed with lidocaine injection solution without preservatives for the purpose of local anaesthesia during administration.

Manufacturer: Fisiopharma S.R.L., Industrial Nucleus, 84020 Palomonte (SA), Italy. Marketing authorisation holder: Viatris AB.

Frequently Asked Questions About Lederspan

References

Editorial Team